MBED represents a highly specialized synthetic small molecule specifically engineered to modulate the calcium homeostasis within striated muscle fibers by acting as a potent allosteric enhancer of the ryanodine receptor type 1 channel while simultaneously exerting inhibitory effects on the sarcoplasmic reticulum calcium ATPase activity, effectively facilitating the measurable elevation of cytosolic calcium concentrations across various preclinical experimental models to evaluate the disruption of intracellular signaling during strictly monitored laboratory observation periods.